Hiscox Ltd Share Price London S.E.
Equities
HSX
BMG4593F1124
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBP | - |
|
05-08 | UBS raises Centrica to 'buy' from 'neutral | AN |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.93B 389B | Sales 2025 * | 4.27B 5.41B 427B | Capitalization | 3.92B 4.97B 392B |
---|---|---|---|---|---|
Net income 2024 * | 466M 591M 46.6B | Net income 2025 * | 500M 634M 50B | EV / Sales 2024 * | 1.14 x |
Net Debt 2024 * | 514M 651M 51.38B | Net Debt 2025 * | 514M 651M 51.38B | EV / Sales 2025 * | 1.04 x |
P/E ratio 2024 * |
8.42
x | P/E ratio 2025 * |
7.74
x | Employees | - |
Yield 2024 * |
2.8% | Yield 2025 * |
3.11% | Free-Float | 97.38% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 21/04/16 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 11/05/22 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 28/02/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 15/11/17 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 19/05/15 |
Colin Keogh
BRD | Director/Board Member | 69 | 18/11/15 |
1st Jan change | Capi. | |
---|---|---|
+53.58% | 67.51B | |
+9.79% | 49.2B | |
+10.51% | 47.75B | |
+37.19% | 37.7B | |
+69.69% | 31.36B | |
+8.28% | 28.53B | |
+23.72% | 24.99B | |
+1.59% | 21.35B | |
+13.75% | 20.5B |
- Stock Market
- Equities
- HSX Stock
- HSX Stock